| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |